Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEJAN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,589
Award facts
- Contract value 100% obligated
- $12,589.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,589.11 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 14, 2026, with an ultimate completion date of January 15, 2026, is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The contract was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. No subcontractors are identified in the award documentation.
This delivery order supports the broader $30.3 billion PPV-G GEN V acquisition strategy, which enables the Defense Logistics Agency to procure comprehensive pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders and its extensive product portfolio encompassing oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals position the company as a critical supplier within the federal pharmaceutical supply chain serving recurring military medical supply needs.
Quick answers
Who was awarded contract SPE2DU26FEJAN?
SPE2DU26FEJAN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DU26FEJAN worth?
The government has obligated $12,589 on SPE2DU26FEJAN.
Is contract SPE2DU26FEJAN an order under another contract?
Yes. SPE2DU26FEJAN is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEJAN competed?
The extent of competition for SPE2DU26FEJAN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award